Get started
Author

Sabira Tahseen

Observed names: S Tahseen, S. Tahseen, Tahseen, Sabira
ORCID: 0000-0002-6887-8149
Observed ORCID: 0000-0002-6887-8149
OpenAlex ID: A5006173411
The 2021 WHO Catalogue of Mycobacterium Tuberculosis Complex Mutations Associated with Drug Resistance: A New Global Standard for Molecular Diagnostics
2021 · Timothy M Walker, Paolo Miotto, et al. · The Lancet Microbe · 265
PDF
Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe
2019 · Martin Hunt, Phelim Bradley, et al. · Wellcome Open Research · 196
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
2016 · Matteo Zignol, Anna S Dean, et al. · The Lancet Infectious Diseases · 176
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
2018 · Matteo Zignol, Andrea Maurizio Cabibbe, et al. · The Lancet Infectious Diseases · 163
PDF
Population structure, biogeography and transmissibility of Mycobacterium tuberculosis
2021 · Luca Freschi, Roger Vargas, et al. · Nature Communications · 154
PDF
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
2020 · Anna S. Dean, Matteo Zignol, et al. · PLoS Medicine · 148
PDF
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
2023 · Lindsay Sonnenkalb, Joshua James Carter, et al. · The Lancet Microbe · 113
PDF
Extrapulmonary tuberculosis in Pakistan- A nation-wide multicenter retrospective study
2020 · Sabira Tahseen, Faisal Masood Khanzada, et al. · PLoS ONE · 110
Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010–2011
2016 · Ejaz Qadeer, Razia Fatima, et al. · PLoS ONE · 75
PDF
Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan
2019 · Arash Ghodousi, Alamdar Hussain Rizvi, et al. · Antimicrobial Agents and Chemotherapy · 74
DeepAMR for predicting co-occurrent resistance of Mycobacterium tuberculosis
2019 · Yang Yang, Timothy M Walker, et al. · Bioinformatics · 71
PDF
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex
2021 · Roger Vargas, Luca Freschi, et al. · Antimicrobial Agents and Chemotherapy · 70
PDF
Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains
2020 · S Battaglia, A Spitaleri, et al. · Journal of Clinical Microbiology · 65
PDF
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
2021 · Koné Kaniga, Rumina Hasan, et al. · Journal of Clinical Microbiology · 62
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
2024 · Ivan Barilar, Simone Battaglia, et al. · Nature Communications · 58
PDF
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
2022 · Viola Dreyer, Ayan Mandal, et al. · Genome Medicine · 50
PDF
GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10,000 Genomes
2020 · Daniel J Wilson, Derrick W Crook, et al. · Molecular Biology and Evolution · 45
PDF
Plasma Antibody Profiles as Diagnostic Biomarkers for Tuberculosis
2011 · Imran H. Khan, Resmi Ravindran, et al. · Clinical and Vaccine Immunology · 40
Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan
2016 · S. Tahseen, E. Qadeer, et al. · The International Journal of Tuberculosis and Lung Disease · 38
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
2022 · Antimycobacterial Susceptibility Testing Group, Sophia B. Georghiou, et al. · European Respiratory Journal · 35
PDF
Delay in diagnosis of tuberculosis in Rawalpindi, Pakistan
2011 · Muhammad AN Saqib, Irum N Awan, et al. · BMC Research Notes · 31
PDF
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward
2019 · Armand Van Deun, Tom Decroo, et al. · International Journal of Antimicrobial Agents · 30
The value of histological examination in the diagnosis of tuberculous lymphadenitis in the era of rapid molecular diagnosis
2022 · Sabira Tahseen, Atiqa Ambreen, et al. · Scientific Reports · 29
PDF
Design of Mannose-Coated Rifampicin nanoparticles modulating the immune response and Rifampicin induced hepatotoxicity with improved oral drug delivery
2021 · Aisha Rauf, Tanveer A. Tabish, et al. · Arabian Journal of Chemistry · 29
Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan
2021 · Asifa Karamat, Atiqa Ambreen, et al. · BMC Infectious Diseases · 29
PDF
Works count: 70
Citation count: 2,499
H-index: 25
I10-index: 42
Year
Topic
Type